Xiaoling Ni
Impact in
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- RNA modifications and cancer 6
- Surgery 17
- Cholangiocarcinoma and Gallbladder Cancer Studies 15
- Co-authors
- Guoyin Kai (7 shared papers)Jianbo Xiao (5 shared papers)Xun Cai (2 shared papers)Tao Suo (29 shared papers)Sheng Shen (25 shared papers)Dayong Jin (5 shared papers)Tiantao Kuang (4 shared papers)Yefei Rong (2 shared papers)
- Journals
- Critical Reviews in Food Science and Nutrition (4 papers)Cancer Science (3 papers)Medical Oncology (2 papers)Phytochemistry Reviews (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoling Ni
54 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 103
- Biochemistry 221
- Cancer Research 209
- Endocrinology, Diabetes and Metabolism 169
- Oncology 250
- Biotechnology 80
Countries citing papers authored by Xiaoling Ni
This map shows the geographic impact of Xiaoling Ni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Ni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Ni more than expected).
Fields of papers citing papers by Xiaoling Ni
This network shows the impact of papers produced by Xiaoling Ni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Ni. The network helps show where Xiaoling Ni may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoling Ni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 292 | |
| 2 | 2013 | 151 | |
| 3 | 2018 | 106 | |
| 4 | 2015 | 91 | |
| 5 | 2011 | 79 | |
| 6 | 2015 | 69 | |
| 7 | 2014 | 69 | |
| 8 | 2012 | 56 | |
| 9 | 2022 | 42 | |
| 10 | 2020 | 37 | |
| 11 | 2009 | 30 | |
| 12 | 2012 | 29 | |
| 13 | 2020 | 27 | |
| 14 | 2019 | 24 | |
| 15 | 2018 | 24 | |
| 16 | 2020 | 20 | |
| 17 | 2020 | 19 | |
| 18 | 2022 | 19 | |
| 19 | 2019 | 18 | |
| 20 | 2018 | 17 |
About Xiaoling Ni
Xiaoling Ni is a scholar working on Molecular Biology, Surgery, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 56 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Gallbladder and Bile Duct Disorders (5 papers), Cancer Cells and Metastasis (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Biochemistry (221 citations), Cancer Research (209 citations), Endocrinology, Diabetes and Metabolism (169 citations), Oncology (250 citations) and Biotechnology (80 citations). Xiaoling Ni has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Guoyin Kai, Jianbo Xiao, Xun Cai, Tao Suo, Sheng Shen, Dayong Jin, Tiantao Kuang, Yefei Rong, Wenchuan Wu and Lijie Cui. Their work appears in journals such as Critical Reviews in Food Science and Nutrition, Cancer Science, Medical Oncology, Phytochemistry Reviews and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.